Noble Depaz <vljnbxxbq@xxxxxxxxxxx>
To: <xfs-masters@xxxxxxxxxxx>
Subject: TTTP.OB High On The Rise! sisccu
Date: Wed, 05 May 2004 11:12:55 -0500
MIME-Version: 1.0
X-Virus-Status: Scanned by norton
Content-Type: text/plain; charset=us-ascii
Content-Transfer-Encoding: plain
nmlupl+++ HOT Trading Alert TTTP.OB - .16 CENTS +++qaingq
OTCBB: TTTP.OB 12 to 20 Plus Enters $400,000,000 Market.
Introduces VisionKare(TM) an Eye Specific Supplement
for Macular Degeneration.
CURRENT_PRICE: $0.16 GET IT NOW!
TARGET_PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80
TARGET_PRICE IN NEXT 10 DAYS: $0.92
Did you miss out on ACST, UP 400%?, ICMH, 130%? and others, don't miss out on
this one TTTP.OB .. hB9}L893129x699w9a5wJ6L
++ EXCITING NEWS JUST RELEASED FOR TTTP ++
Before we start with the profile of TTTP we would like to mention something
very important: THERE IS BIG PR CAMPAIGN STARTING on May 5th ITS EXPECTED THERE
WILL BE HUGE DEMAND FOR TTTP.OB SHARES.
SO TAKE ADVANTAGE AND GET IN EARLY. THE TARGET PRICES BELOW ARE PRETTY MUCH
REALISTIC.
+>+>+> Company Profile +>+>+>
12 to 20 Plus, Inc (otcbb:TTTP)
Symbol: TTTP.OB
Current Price: $0.16
TARGET PRICE IN NEXT 3-5 DAYS: $0.75 - 0.80
TARGET PRICE IN NEXT 10 DAYS: $0.92
How many times have you seen good stocks but you couldn't get your hands on
them in the right moment? We are alerting you to a special company with a
unique product that is set to be profiled by many newsletters in the next 5-10
days -- this is your chance to get in!
----------------------------------------------
ABOUT THE COMPANY
TTTP is an innovative company with a 21st century approach to the health issues
of today. Unlike traditional treatment regimens, TTTP?s approach focuses on
less harmful and more natural forms of therapies that yield effective results
while minimizing chemical dependence or harsh side effects. 12 to 20 Plus?
believes it has a successful prescription for growth?attracting, retaining and
successfully treating integrative health-conscious consumers. 12 to 20 Plus has
the products to fit the dynamics and trends of a global market.
We Expect some strong demand for this stock in the near future!!!!!
xvrikp---------------------------------------fannur
NEWS RELEASE...pmfgyq
SAN LUIS OBISPO, CA,, Apr. 30, 2004 (MARKET WIRE via COMTEX) -- (TTTP) --
According to a recent poll, Americans dread blindness more than any other
disability. Recent studies indicate that by the year 2025, the population of
people over the age of 65 in the United States will be six times higher than in
1990. The reason -- "baby boomers" are aging and overall life expectancy is
increasing. Since many people diagnosed with macular degeneration are over age
55, the number of cases of macular degeneration in the U.S. will increase
significantly as baby boomers age.
Said Carol Slavin, President "The market is very large, with about 50 million
AMD sufferers worldwide (15 million in the U.S.) and five million new cases
each year. Less than 2% of all AMD cases are treated successfully, so an urgent
need exists for effective new strategies." We would anticipate significant
revenues in the millions of dollars as we increase our distribution
capabilities and our VisionKare(TM) brand becomes the "benchmark" for the
industry.
--------------------qcqidy--------------lrxlos
*Forward-Looking...Statements-Disclaimer..biqhkg
Information within this email contains "forward looking statements" within the
meaning of Section 27A of the Securities Act of 1933 and Section 21B of the
Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, goals, expectations, beliefs, plans,
projections, objectives, assumptions or future events or performance are not
statements of historical fact and may be "forward looking statements."
fxpwku lmhdqx vwlhqk hdpjni aophog ydknrt jrghqr
helrhd wmvwdl stltax rradli
|